Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: a retrospective cohort study
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2026.02.006 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Roger Kou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Anticoagulants, Neoplasms, Venous Thromboembolism, Pulmonary Embolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: University of Ottawa.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
BACKGROUND: The anticoagulant management and outcomes in patients with cancer and distal lower extremity deep vein thrombosis (dDVT) or subsegmental pulmonary embolism (SSPE) remain unclear. OBJECTIVES: The objective of this study was to assess the anticoagulation management strategies for dDVT and/or SSPE in patients with cancer and their associated outcomes. METHODS: We conducted a single-center retrospective cohort study in patients ≥18 years old with active cancer and dDVT and/or SSPE. Patients were followed for 12 months or until death. The primary efficacy outcome was recurrent venous thromboembolism (VTE) at 6 months, and the primary safety outcome was major bleeding. We calculated the cumulative incidence of outcomes with 95% CI, considering death as a competing risk. RESULTS: We identified 149 patients with isolated dDVT and 119 with SSPE ± dDVT. Anticoagulation was initiated in 85% of patients, most often with therapeutic doses. The 6-month cumulative incidences of recurrent VTE in the dDVT and SSPE cohorts were 17.9% (95% CI, 12.1-24.6) and 7.1% (95% CI, 3.3-12.9), respectively. The 6-month cumulative incidences of major bleeding were 7.9% (95% CI, 4.0-13.5) and 5.5% (95% CI, 2.2-10.9), respectively. Exploratory analysis stratified by the use of anticoagulation showed that patients not initiated on anticoagulation had a numerically higher incidence of recurrent VTE in the dDVT group. CONCLUSION: Patients with cancer-associated dDVT and/or SSPE had a substantial risk of recurrent VTE, especially in those not on anticoagulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Ottawa, Ottawa, Canada.
- The Ottawa Hospital Research Institute, Ottawa, Canada.
- The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine and Surgery, Research Center on Thromboembolic Diseases and Antithrombotic Treatment, University of Insubria, Varese, Italy.
- The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Canada.
- The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Canada. Electronic address: https://x.com/DellucAurelien.
- The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Canada. Electronic address: https://x.com/MarcCarrier1.
Förderung
- University of Ottawa
Zitieren
APA
Kou, R., Mallick, R., Brown, C., Hrubesz, G., Mckeague, S., Tokessy, L., Girardi, L., Le Gal, G., Delluc, A., Carrier, M., & Wang, T. F. (2026). Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: a retrospective cohort study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.02.006
Vancouver
Kou R, Mallick R, Brown C, Hrubesz G, Mckeague S, Tokessy L, et al. Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: a retrospective cohort study. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.02.006
BibTeX
@article{Kou2026,
author = {Kou, Roger and Mallick, Ranjeeta and Brown, Cameron and Hrubesz, Gabriella and Mckeague, Sarah and Tokessy, Lauren and Girardi, Laura and Le Gal, Grégoire and Delluc, Aurélien and Carrier, Marc and Wang, Tzu-Fei},
title = {Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: a retrospective cohort study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2026.02.006}
}
EUVIMED